Capha Pharmaceuticals Inc. (FPSUF) Research

Capha Pharmaceuticals Inc. currently conducts very limited business operations. Its strategic aim is to delve into and pursue opportunities within the pharmaceutical distribution industry. The company, which was founded in 2004, previously operated as FPS Pharma Inc. until it adopted its present name, Capha Pharmaceuticals Inc., in January 2017. It is headquartered in West Kelowna, Canada.

Market snapshot

Symbol
FPSUF
Price
$0.00
Day change
0.00%
Market cap
$9.1K
P/E ratio
-0.21x
52-week range
0.000001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • American Bio Medica Corporation (ABMC)
  • Acacia Diversified Holdings, Inc. (ACCA)
  • Gene Biotherapeutics, Inc. (CRXM)
  • American CryoStem Corporation (CRYO)
  • E-Qure Corp. (EQUR)
  • Goodbody Health Limited (GDBYF)
  • Gelesis Holdings, Inc. (GLSHQ)
  • EastWest Bioscience Inc. (HBOSF)

Open Capha Pharmaceuticals Inc. (FPSUF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.